High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$13.7M
$13,684,646
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$158,320x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $158,320x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$92,846x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $92,846x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Leonard Keith R
• Director
10b5-1 SellΔOwn -64.0%
2026-03-02
$997,195
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -64.0%
|
2026-03-02 | $997,195 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-03-02
$220,943x3
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $220,943x3 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $71,844x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$940,528x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $940,528x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -16.7%
2026-03-02
$256,518
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -16.7%
|
2026-03-02 | $256,518 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-27
$92,934
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-27 | $92,934 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.8%
2026-02-04
$252,748
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.8%
|
2026-02-04 | $252,748 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-02-02
$93,707
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $93,707 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$52,323
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $52,323 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-02-02
$1,027,293Largex4
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $1,027,293Largex4 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $33,658 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$505,710
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $505,710 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -14.3%
2026-02-02
$250,483
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -14.3%
|
2026-02-02 | $250,483 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.5%
2025-12-15
$332,851
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.5%
|
2025-12-15 | $332,851 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2025-12-01
$50,091
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-01 | $50,091 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -11.1%
2025-12-01
$302,133
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-12-01 | $302,133 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
LIN SUE-JEAN
• Director
Discretionary SellΔOwn -48.6%
2025-11-24
$777,956
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Discretionary SellΔOwn -48.6%
|
2025-11-24 | $777,956 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-24
$1,485,755Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-24 | $1,485,755Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-21
$31,650
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-21 | $31,650 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Gilbert Halley E
• Director
Discretionary SellΔOwn -42.8%
2025-11-20
$455,442
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Discretionary SellΔOwn -42.8%
|
2025-11-20 | $455,442 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-19
$72,135x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-19 | $72,135x2 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-13 | $939,494x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -14.9%
2025-11-06
$417,145
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -14.9%
|
2025-11-06 | $417,145 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Discretionary SellΔOwn -16.2%
2025-11-06
$732,927
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Discretionary SellΔOwn -16.2%
|
2025-11-06 | $732,927 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 Sell
2025-11-05
$91,643
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-05 | $91,643 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2025-11-03
$64,806x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $64,806x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-03
$178,156x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $178,156x2 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2025-11-03 | $2,175 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2025-11-03
$285,399x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $285,399x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -10.0%
2025-11-03
$252,669
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -10.0%
|
2025-11-03 | $252,669 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-28
$1,001,032Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-28 | $1,001,032Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2025-10-02
$90,263x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-10-02 | $90,263x2 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-02
$415,574
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-02 | $415,574 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$469,074x2
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $469,074x2 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-01 | $189,227x2 | S | Form 4 |